ACCESSION: MSBNK-SMB_Measured-HSA001P0155008
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 19
COMMENT: RAW_SPEC {'7_posi_2435': {'bp': 654033.0, 'sum': 1862416.0}, '7_posi_2351': {'bp': 647239.0, 'sum': 1686527.0}, '7_posi_2538': {'bp': 641306.0, 'sum': 1586718.0}, '3_posi_2309': {'bp': 627277.0, 'sum': 1895657.0}, '10_posi_2330': {'bp': 625767.0, 'sum': 1869532.0}, '12_posi_2601': {'bp': 623122.0, 'sum': 1242679.0}, '11_posi_2329': {'bp': 588494.0, 'sum': 1656529.0}, '17_posi_2351': {'bp': 565659.0, 'sum': 1684965.0}, '13_posi_2414': {'bp': 561940.0, 'sum': 1637289.0}, '5_posi_2265': {'bp': 555622.0, 'sum': 1663843.0}, '1_posi_2372': {'bp': 553616.0, 'sum': 1730083.0}, '14_posi_2329': {'bp': 549807.0, 'sum': 1760970.0}, '16_posi_2350': {'bp': 525891.0, 'sum': 1849314.0}, '13_posi_2496': {'bp': 523192.0, 'sum': 1555481.0}, '13_posi_2581': {'bp': 518727.0, 'sum': 1322883.0}, '18_posi_2455': {'bp': 517252.0, 'sum': 1544531.0}, '1_posi_2286': {'bp': 509934.0, 'sum': 1644708.0}, '15_posi_2329': {'bp': 490680.0, 'sum': 1386839.0}, '17_posi_2623': {'bp': 454736.0, 'sum': 1178602.0}}
COMMENT: RETENTION_TIME_STDEV 0.222
COMMENT: PRECURSOR_M/Z_RAW 155.128763
COMMENT: PRECURSOR_M/Z_STDEV 0.000041
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.130; C7H14N4; [M+H]+; delta(ppm) -0.129767
COMMENT: PROPOSED_MF MS-FINDER 3.776; C7H14N4; [M+H]+; delta(ppm) -0.134779
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.866; C7H14N4; [M+H]+; delta(ppm) -0.134779
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.706; C9H16NO; [M+H]+; delta(ppm) -8.789838
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H14N4; [M+H]+; delta(ppm) -0.134779
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.547; VPTPVJMIJOZPON-UHFFFAOYNA-N; [M+H]+; NC(CCCNC(N)=N)C#C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.286; NVUJPUOLLHDTEO-UHFFFAOYSA-N; [M+H]+; N#CN=C(NC)NC(C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.250; VZVGEDRCVUKSEL-UHFFFAOYSA-N; [M+H]+; CCC(C)(C)NC(=N)NC#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.945; VPTPVJMIJOZPON-UHFFFAOYNA-N; [M+H]+; &alpha; -ethynylagmatine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.817; VZVGEDRCVUKSEL-UHFFFAOYSA-N; [M+H]+; guancidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.817; NVUJPUOLLHDTEO-UHFFFAOYSA-N; [M+H]+; N'-tert-butyl-N''-cyano-N-methylguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VPTPVJMIJOZPON-UHFFFAOYNA-N; [M+H]+; &alpha; -ethynylagmatine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.983; VZVGEDRCVUKSEL-UHFFFAOYSA-N; [M+H]+; guancidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.946; NVUJPUOLLHDTEO-UHFFFAOYSA-N; [M+H]+; N'-tert-butyl-N''-cyano-N-methylguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.763; VZVGEDRCVUKSEL-UHFFFAOYSA-N; [M+H]+; 1-cyano-2-(2-methylbutan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.390; WXMJWQSOWLXJOA-UHFFFAOYSA-N; [M+H]+; 1,3,5-triazatricyclo[3.3.1.13,7]decan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.171; DDAAGLMJYOHBDU-UHFFFAOYSA-N; [M+H]+; 1-[2-(dimethylamino)ethyl]pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.056; QKZGPGWTHXRTLI-UHFFFAOYSA-N; [M+H]+; 1-[2-(dimethylamino)ethyl]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.008; GKERKLLAMVQMOK-UHFFFAOYSA-N; [M+H]+; 3-N-ethyl-2,5-dimethylpyrazole-3,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.963; HTBNRMWFFNIJSW-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(4-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.956; DRBNIMQCGWBAAI-UHFFFAOYSA-N; [M+H]+; 1-(3-propan-2-yl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.954; PLACVJNEVHWHIO-ZCFIWIBFSA-N; [M+H]+; (1R)-1-(1-propan-2-yltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.954; GSFXHRLTEGWUDC-UHFFFAOYSA-N; [M+H]+; 2-(3-propan-2-yl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.950; GQKWVZQMZJGFRX-UHFFFAOYSA-N; [M+H]+; 2-(4-propan-2-yl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.950; WPOPKALCUXTWBT-UHFFFAOYSA-N; [M+H]+; 3-(4,5-dimethyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.950; QWKTZRXNVNHUGQ-UHFFFAOYSA-N; [M+H]+; 2-(5-ethyl-4-methyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.949; UUJBKYUVARGEOD-UHFFFAOYSA-N; [M+H]+; 3-(3,5-dimethyl-1,2,4-triazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.826; ULEKLGWVNKDOTE-UHFFFAOYSA-N; [M+H]+; 4-(azidomethyl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.814; MQGSRYDOBMLBLN-UHFFFAOYSA-N; [M+H]+; 4-(2-azidoethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.812; MARPOIGQCYGLBN-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.787; VPTPVJMIJOZPON-UHFFFAOYSA-N; [M+H]+; 2-(4-aminohex-5-ynyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.712; OYXNTYRBYKSGGN-LURJTMIESA-N; [M+H]+; (1S)-1-(3,5-dimethyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.704; DWJOCVCEHVJGEG-UHFFFAOYSA-N; [M+H]+; (1-tert-butyltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.698; XBDAQUIRZHEBOJ-UHFFFAOYSA-N; [M+H]+; (2-tert-butyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.694; VVMUXKXUTWVUBL-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.581; LUTYSHHATVYMSC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(2-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -30.698; XWNNLILJNAOZJV; [M+H]+; 1-(4,5-dihydro-1H-imidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -50.285; JMMBFKMTFVJLBY; [M+H]+; 1-(4,5-Dihydroimidazol-1-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -56.051; RCAWJJWAKWSQIN; [M+H]+; N'-(1H-pyrazin-4-ylmethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -58.674; IGNXSHLJGMTVCQ; [M+H]+; N'-methyl-N-methylidenepiperazine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.418; GEEFFCGXEZMMQC; [M+H]+; 4-Ethenylpiperazine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.187; ORLGXWSZINCCTK; [M+H]+; 2-[4-(Aminomethyl)piperazin-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.937; ZBCPFPVFQOHNKJ; [M+H]+; 1-ethyl-3-[(E)-ethylideneamino]imidazolidin-2-imine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -70.372; OLQBOEQFFXVBCD; [M+H]+; N'-(2H-pyrazin-1-ylmethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -70.518; PDBKBYUNDIXSIP; [M+H]+; N-(azetidin-3-yl)-N-methyl-4,5-dihydro-1H-imidazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.254; ZLPYMWSZHDOEFD; [M+H]+; (E)-N'-(4,5-dihydro-1H-imidazol-2-yl)but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.756; XWNNLILJNAOZJV; [M+H]+; 1-(4,5-dihydro-1H-imidazol-2-yl)piperazine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H15N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.827
MS$FOCUSED_ION: PRECURSOR_M/Z 155.129102
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0bt9-2900000000-d9f731a71a5bc3b7b60a
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0650807 15.7096 58.065717 1.2400 3.46 0.1825 19 f{C3H8N1}/-0.77ppm,p-C4H7N3
  69.0447128 49.8496 69.045338 1.1876 12.13 0.2035 19 f{C3H5N2}/-0.17ppm,p-C4H10N2
  70.0650065 8.8153 70.065626 1.9411 2.32 0.6464 15 f{C4H8N1}/-1.70ppm,p-C3H7N3
  71.0603715 62.8119 71.060985 0.9429 25.63 0.1982 19 f{C3H7N2}/-0.04ppm,p-C4H8N2
  72.0442506 12.6401 72.044857 1.1660 3.66 0.3431 17 ?
  83.0602636 9.6789 83.060767 2.3236 4.06 -0.0214 15 f{C4H7N2}/-1.34ppm,p-C3H8N2
  85.0760282 110.3882 85.076507 0.3174 18.95 0.4070 19 f{C4H9N2}/0.04ppm,p-C3H6N2
  86.0600119 7.8640 86.060479 1.7197 2.00 0.1341 14 ?
  86.0712130 15.5579 86.071680 1.2780 5.96 0.1474 19 f{C3H8N3}/-0.70ppm,p-C4H7N1
  87.0552403 13.1174 87.055694 1.6426 5.56 -0.0072 18 ?
  87.0917022 207.3700 87.092155 0.1608 71.53 0.1211 19 f{C4H11N2}/0.32ppm,p-C3H4N2
  97.0758744 10.2886 97.076219 2.1942 3.22 -0.1471 16 f{C5H9N2}/-1.55ppm,p-C2H6N2
  111.0916491 22.9928 111.091865 1.7643 8.07 0.1754 19 f{C6H11N2}/-0.23ppm,p-C1H4N2
  112.0869680 193.3272 112.087173 0.3301 17.62 0.7842 19 f{C5H10N3}/0.39ppm,p-C2H5N1
  114.0662061 603.4734 114.066388 0.2367 162.28 0.0632 19 ?
  114.0913317 21.4126 114.091514 1.7267 4.47 0.1684 19 ?
  127.0867767 8.6242 127.086789 3.3127 2.68 -0.3451 14 ?
  138.0660538 25.6578 138.065959 1.4993 11.76 0.0072 18 ?
  138.1024878 14.8746 138.102393 1.8754 4.91 0.2446 18 f{C7H12N3}/-0.62ppm,p-H3N1
  155.0706691 15.6919 155.070564 2.5666 4.45 -0.1298 19 ?
  155.0815875 257.3436 155.081482 0.6513 78.14 0.0860 19 ?
  155.1290287 999.0000 155.128923 0.1740 0.00 1.0000 19 f{C7H15N4}/-0.61ppm,p
  155.1539314 32.0859 155.153826 3.5191 7.19 0.0098 17 ?
PK$NUM_PEAK: 23
PK$PEAK: m/z int. rel.int.
  58.065081 15.71 15
  69.044713 49.85 49
  70.065006 8.82 8
  71.060371 62.81 62
  72.044251 12.64 12
  83.060264 9.68 9
  85.076028 110.39 110
  86.060012 7.86 7
  86.071213 15.56 15
  87.055240 13.12 13
  87.091702 207.37 207
  97.075874 10.29 10
  111.091649 22.99 22
  112.086968 193.33 193
  114.066206 603.47 603
  114.091332 21.41 21
  127.086777 8.62 8
  138.066054 25.66 25
  138.102488 14.87 14
  155.070669 15.69 15
  155.081588 257.34 257
  155.129029 999.00 999
  155.153931 32.09 32
//
